FDA Funding Debate Reframed By GAO Reports On Strategic Planning
This article was originally published in The Pink Sheet Daily
Republican senators argue reports show that FDA needs significant reform; discussion of Cures and User Fee legislation will now likely focus on what the plan should be.
You may also be interested in...
Agency documents its regulatory science accomplishments to advance product development and manufacturing and ensure the safety and effectiveness of marketed products.
GAO report prompts vigorous action – and some defensiveness – by the agency.
After staff complain about becoming the 'Botox police,' a House committee is asking FDA for an update on two previous reports raising issues of management and morale in the Office of Criminal Investigations.